|
AU6008101A
|
|
Benzophenones as inhibitors of il-1beta and tnf-alpha
|
|
AU2833001A
|
|
Vitamin D-derivatives and their use in treating osteoporosis and related bone disorders
|
|
AU1693501A
|
|
Aminobenzophenones as inhibitors of IL-1beta and TNF-alpha
|
|
EP1232173A1
|
|
Fusidic acid derivatives
|
|
EP1224321A2
|
|
A method of screening for substances acting on msk1
|
|
AU5806900A
|
|
Aminobenzophenones as inhibitors of IL-1beta and TNF-alpha
|
|
HU0201909A2
|
|
Aminobenzophenones as inhibitors of il-1betha and tnf-alpha, process for producing them and pharmaceutical compositions containing them
|
|
HU0201910A2
|
|
Novel aminobenzophenones, pharmaceutical compositions containing them and their use
|
|
HU0201913A2
|
|
Aminobenzophenones as inhibitors of il-1 betha and tnf-alpha and pharmaceutical compositions containing them
|
|
AU5806800A
|
|
Aminobenzophenones as inhibitors of IL-1beta and TNF-alpha
|
|
US6897236B1
|
|
Aminobenzophenones as inhibitors of IL-1β and TNF-α
|
|
PL356968A1
|
|
Solubilized pharmaceutical composition for parenteral administration
|
|
AU2278300A
|
|
Pharmaceutical composition
|
|
AU6189299A
|
|
Method for the production of feed pellets, mix of a premix and vitamin premix
|
|
AU4602399A
|
|
Prolonged release ophthalmic compositions containing a fluoroquinolone
|
|
GB9909442D0
|
|
Chemical compounds
|
|
CZ20003184A3
|
|
Matrix metalloproteinase inhibitors
|
|
CZ9904237A3
|
|
Cyanoguanidines functioning as cell proliferation inhibitors
|
|
CZ9904238A3
|
|
Cyanoguanidines functioning as inhibitors of cell proliferation
|
|
CZ9904239A3
|
|
Cyanoamidines functioning as inhibitors of cell proliferation
|
